Edition:
United Kingdom

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

14.78USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$14.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
4,341
52-wk High
$21.71
52-wk Low
$5.70

Chart for

About

Acer Therapeutics Inc., formerly Opexa Therapeutics, Inc., is a pharmaceutical company. The Company is engaged in acquires, develops and intends to commercialize therapies for patients with serious rare diseases with critical unmet medical need. Its late-stage clinical pipeline includes Edsivo (celiprolol) and ACER-001. The... (more)

Overall

Beta: 2.33
Market Cap(Mil.): $12.90
Shares Outstanding(Mil.): 0.74
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.65 16.44
EPS (TTM): -- -- --
ROI: -- 2.35 10.62
ROE: -- 2.95 14.20

BRIEF-Acer Therapeutics Q3 loss per share $1.09

* Acer Therapeutics reports third quarter 2017 financial results and provides corporate update

13 Nov 2017

BRIEF-Acer Therapeutics welcomes two new members to its board

* Acer Therapeutics welcomes two new members to its board of directors

12 Oct 2017

Earnings vs. Estimates